Two Sigma Investments’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-511
| Closed | -$7.45K | – | 3348 |
|
|
2023
Q4 | $7.45K | Sell |
511
-19
| -4% | -$277 | ﹤0.01% | 3004 |
|
|
2023
Q3 | $12.6K | Buy |
+530
| New | +$12.6K | ﹤0.01% | 2814 |
|
|
2023
Q1 | – | Sell |
-408
| Closed | -$34K | – | 3173 |
|
|
2022
Q4 | $34K | Sell |
408
-64
| -14% | -$5.33K | ﹤0.01% | 2575 |
|
|
2022
Q3 | $43K | Buy |
+472
| New | +$43K | ﹤0.01% | 2280 |
|
|
2022
Q2 | – | Sell |
-1,698
| Closed | -$412K | – | 2961 |
|
|
2022
Q1 | $412K | Sell |
1,698
-11,150
| -87% | -$2.71M | ﹤0.01% | 2066 |
|
|
2021
Q4 | $3.89M | Sell |
12,848
-1,746
| -12% | -$528K | 0.01% | 1004 |
|
|
2021
Q3 | $6.04M | Buy |
+14,594
| New | +$6.04M | 0.01% | 817 |
|
|
2021
Q2 | – | Sell |
-443
| Closed | -$91K | – | 2976 |
|
|
2021
Q1 | $91K | Sell |
443
-244
| -36% | -$50.1K | ﹤0.01% | 2232 |
|
|
2020
Q4 | $137K | Buy |
687
+549
| +398% | +$109K | ﹤0.01% | 1874 |
|
|
2020
Q3 | $23K | Sell |
138
-880
| -86% | -$147K | ﹤0.01% | 1808 |
|
|
2020
Q2 | $253K | Buy |
1,018
+444
| +77% | +$110K | ﹤0.01% | 1678 |
|
|
2020
Q1 | $105K | Sell |
574
-845
| -60% | -$155K | ﹤0.01% | 1724 |
|
|
2019
Q4 | $411K | Buy |
+1,419
| New | +$411K | ﹤0.01% | 1763 |
|
|
2019
Q2 | – | Sell |
-364
| Closed | -$97K | – | 2487 |
|
|
2019
Q1 | $97K | Sell |
364
-385
| -51% | -$103K | ﹤0.01% | 2004 |
|
|
2018
Q4 | $159K | Buy |
+749
| New | +$159K | ﹤0.01% | 1906 |
|
|
2018
Q3 | – | Sell |
-298
| Closed | -$121K | – | 2418 |
|
|
2018
Q2 | $121K | Buy |
+298
| New | +$121K | ﹤0.01% | 1930 |
|
|
2018
Q1 | – | Sell |
-1,216
| Closed | -$734K | – | 2404 |
|
|
2017
Q4 | $734K | Buy |
+1,216
| New | +$734K | ﹤0.01% | 1602 |
|